Delivery Order SPE2DB25D7060-SPE2DB25FXSRF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,736.79 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-competitive delivery order was issued on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TYPHIM VI (typhoid vaccine) 25 mcg/0.5 mL syringes valued at $55,192.00 on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a small transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $12,086.06 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-set-aside delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $4,513.01 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This contract represents a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $45,117.27 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product, with an ultimate completion date of June 26, 2025. The contract was awarded on a firm fixed-price basis with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product, under a firm fixed-price contract. The award, issued on August 12, 2025, carries a ceiling value of $8,632.90 and is scheduled for completion by August 13, 2025. This is a competitively awarded, non-set-aside delivery order with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $27,708.84 to AmerisourceBergen Drug Corp for the supply of TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.60 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,388.17 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a firm fixed price, competitively awarded contract with no set-aside designation. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.76 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (typhoid vaccine) on July 18, 2025, with completion targeted for July 21, 2025. This firm fixed price delivery order represents a pediatric vaccine procurement to support federal medical supply requirements. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB25FXSRFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,485.75 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism, which covers specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 8/5/25 |